111 Price to Sales Ratio 2018-2024 | YI
111 P/S Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
2025-04-22 | 8.38 | 0.03 | |
2024-09-30 | 7.56 | $241.16 | 0.03 |
2024-06-30 | 10.65 | $240.89 | 0.04 |
2024-03-31 | 11.60 | $242.97 | 0.05 |
2023-12-31 | 15.50 | $250.23 | 0.06 |
2023-09-30 | 26.00 | $248.64 | 0.10 |
2023-06-30 | 24.60 | $245.69 | 0.10 |
2023-03-31 | 26.50 | $243.07 | 0.11 |
2022-12-31 | 30.20 | $235.30 | 0.13 |
2022-09-30 | 26.80 | $235.75 | 0.11 |
2022-06-30 | 20.60 | $241.86 | 0.09 |
2022-03-31 | 26.60 | $243.92 | 0.11 |
2021-12-31 | 35.00 | $235.18 | 0.15 |
2021-09-30 | 61.70 | $222.39 | 0.28 |
2021-06-30 | 90.85 | $202.02 | 0.45 |
2021-03-31 | 138.00 | $173.39 | 0.80 |
2020-12-31 | 69.50 | $152.64 | 0.46 |
2020-09-30 | 62.00 | $120.68 | 0.51 |
2020-06-30 | 63.50 | $97.40 | 0.65 |
2020-03-31 | 66.10 | $84.45 | 0.78 |
2019-12-31 | 67.30 | $69.33 | 0.97 |
2019-09-30 | 48.70 | $61.90 | 0.79 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $0.064B | $1.973B |
111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Veeva Systems (VEEV) | United States | $35.134B | 48.53 |
Tempus AI (TEM) | United States | $6.966B | 0.00 |
Hims & Hers Health (HIMS) | United States | $6.050B | 97.25 |
Inspire Medical Systems (INSP) | United States | $4.470B | 86.83 |
IRhythm Technologies (IRTC) | United States | $3.223B | 0.00 |
Privia Health (PRVA) | United States | $2.873B | 215.27 |
Schrodinger (SDGR) | United States | $1.881B | 0.00 |
Clover Health Investments (CLOV) | United States | $1.839B | 0.00 |
Enovis (ENOV) | United States | $1.825B | 11.29 |
Omnicell (OMCL) | United States | $1.418B | 30.59 |
Phreesia (PHR) | United States | $1.409B | 0.00 |
Azenta (AZTA) | United States | $1.154B | 53.72 |
10x Genomics (TXG) | United States | $0.918B | 0.00 |
Butterfly Network (BFLY) | United States | $0.568B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.551B | 0.00 |
Talkspace (TALK) | United States | $0.450B | 267.00 |
Veradigm (MDRX) | United States | $0.449B | 0.00 |
Standard BioTools (LAB) | United States | $0.440B | 0.00 |
TruBridge (TBRG) | United States | $0.363B | 0.00 |
Claritev (CTEV) | United States | $0.325B | 0.00 |
Health Catalyst (HCAT) | United States | $0.270B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.206B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.189B | 0.00 |
Pulmonx (LUNG) | United States | $0.182B | 0.00 |
American Well (AMWL) | United States | $0.109B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.100B | 0.00 |
Retrieve Medical Holdings (RMHI) | United States | $0.082B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.076B | 0.00 |
P3 Health Partners (PIII) | United States | $0.066B | 0.00 |
CareCloud (CCLD) | United States | $0.060B | 2.58 |
HeartBeam (BEAT) | United States | $0.055B | 0.00 |
Outset Medical (OM) | United States | $0.040B | 0.00 |
Zepp Health (ZEPP) | China | $0.039B | 0.00 |
Zhongchao (ZCMD) | China | $0.030B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.014B | 0.00 |
MSP Recovery (MSPR) | United States | $0.014B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.010B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
Precipio (PRPO) | United States | $0.009B | 0.00 |
Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
Movano (MOVE) | United States | $0.007B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
HeartSciences (HSCS) | United States | $0.004B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
Syra Health (SYRA) | United States | $0.001B | 0.00 |
Future Health ESG (FHLT) | United States | $0.000B | 0.00 |